Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in paigen diet-fed apolipoprotein E deficient mice

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Yesilaltay, Ayce ^a   Daniels, Kathleen ^b   Pal, Rinku ^b   Krieger, Monty ^a   Kocher, Olivier ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; PDZ PROTEIN; PDZK1 PROTEIN; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENIC DIET; CHEMOLUMINESCENCE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISEASE SEVERITY; FAST PROTEIN LIQUID CHROMATOGRAPHY; GENOTYPE; HEART INFARCTION; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNOHISTOCHEMISTRY; MALE; MORPHOLOGY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEPLETION; PROTEIN DOMAIN;

ANIMALS; ANTIGENS, CD36; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; CORONARY OCCLUSION; DIETARY FATS; IMMUNOBLOTTING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPROTEINS; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION;

ANIMALIA; MURINAE; MUS;

EID: 77949537103     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008103     Document Type: Article

References (46)

1. Kumar V, Abbas A, Fausto N (2005) Robbin's and Cotran pathologic basis of disease. Elsevier and Saunders. pp 516-525.
2. Chase A, Jackson C, Angelini G, Suleiman M (2007) Coronary artery disease progression is associated with increased resistance of hearts and myocytes to cardiac insults. Crit Care Med 35: 2344-2351.
3. Zhang S, Reddick R, Piedrahita J, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471.
4. Nakashima Y, Plump A, Raines E, Breslow J, Ross R (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14: 133-140.
5. Plump A, Smith J, Hayek T, Aalto-Setala K, Walsh A, et al. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353.
6. Zhang S, Reddick R, Burkey B, Maeda N (1994) Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 94: 937-945.
7. Reardon C, Getz G (2001) Mouse models of atherosclerosis. Curr Opin Lipidol 12: 167-173.
8. Barr D, Russ E, Eder H (1951) Protein-lipid relationships in human plasma. II. In athrosclerosis and related conditions. Am J Med 11: 480-488.
9. Kannel W, Dawber T, Kagan A, Revotskie N, Stokes Jr (1961) Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med 55: 33-50.
10. Miller G, Miller N (1975) Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1.
11. Braun A, Trigatti BL, Post MJ, Sato K, Simons M, et al. (2002) Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 90: 270-276.
12. Trigatti B, Rayburn H, Vinals M, Braun A, Miettinen H, et al. (1999) Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A 96: 9322-9327.
13. Glomset J (1968) The plasma lecithin:cholesterol acyltrans ferase reaction. J Lipid Res 9: 155-167.
14. Krieger M (1999) Charting the fate of the ''Good Cholesterol'': identification and characterization of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem 68: 523-558.
15. Rigotti A, Miettinen H, Krieger M (2003) The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocrine Reviews 24: 357-387.
16. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, et al. (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271: 518-520.
17. Acton SL, Scherer PE, Lodish HF, Krieger M (1994) Expression cloning of SRBI, a CD36-related class B scavenger receptor. J Biol Chem 269: 21003-21009.
18. Landschulz KT, Pathak R, Rigotti A, Krieger M, Hobbs HH (1996) Regulation of scavenger receptor, class B type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest 98: 984-995.
19. Mineo C, Deguchi H, Griffin J, Shaul PW (2006) Endothelial and antithrombotic actions of HDL. Circ Res 98: 1352-1364.
20. Zhu W, Saddar S, Seetharam D, Chambliss K, Longoria C, et al. (2008) The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ Res 102: 480-487.
21. Kocher O, Yesilaltay A, Shen C, Zhang S, Daniels K, et al. (2008) Influence of PDZK1 on Lipoprotein Metabolism and Atherosclerosis Biochim Biophys Acta 1782: 310-316.
22. Arai T, Wang N, Bezouevski M, Welch C, Tall A (1999) Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scaveger receptor BI transgene. J Biol Chem 274: 2266-2271.
23. Kozarsky K, Donahee M, Glick J, Krieger M, Rader D (2000) Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 20: 721-727.
24. Ueda Y, Gong E, Royer L, Cooper P, Francone O, et al. (2000) Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem 275: 20368-20373.
25. Zhang Y, Da Silva J, Reilly M, Billheimer J, Rothblat G, et al. (2005) Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest 115: 2870-2874.
26. Covey S, Krieger M, Wang W, Penman M, Trigatti B (2003) Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptornegative mice involves its expression in bone marrow-derived cells. Arterioscler Thromb Vasc Biol 23: 1589-1594.
27. Huszar D, Varban M, Rinninger F, Feeley R, Arai T, et al. (2000) Increased LDL cholesterol and atherosclerosis in LDL receptor-defficient mice with attenuated expression of scavenger receptor B1. Arterioscler Thromb Vasc Biol 20: 1068-1073.
28. Van Eck M, Twisk J, Hoekstra M, Van Rij B, Van der Lans C, et al. (2003) Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver. J Biol Chem 278: 23699-23705.
29. Caligiuri G, Levy B, Pernow J, Thoren P, Hansson G (1999) Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci U S A 96: 6920-6924.
30. Ikemoto M, Arai H, Feng D, Tanaka K, Aoki J, et al. (2000) Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I. Proc Natl Acad Sci U S A 97: 6538-6543.
31. Kocher O, Comella N, Tognazzi K, Brown LF (1998) Identification and partial characterization of PDZK1: A novel protein containing PDZ interaction domains. Lab Invest 78: 117-125.
32. Kocher O, Yesilaltay A, Cirovic C, Pal R, Rigotti A, et al. (2003) Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism. J Biol Chem 278: 52820-52825.
33. Yesilaltay A, Kocher O, Rigotti A, Krieger M (2005) Regulation of SR-BImediated high-density lipoprotein metabolism by the tissue-specific adaptor protein PDZK1. Curr Opin Lipidol 16: 147-152.
34. Zuliani G, Arca M, Signore A, Bader G, Fazio S, et al. (1999) Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia. Arterioscler Thromb Vasc Biol 19: 802-809.
35. Kocher O, Pal R, Roberts M, Cirovic C, Gilchrist A (2003) Targeted disruption of the PDZK1 gene by homologous recombination. Mol Cell Biol 23: 1175-1180.
36. Paigen B, Morrow A, Brandon C, Mitchell D, Holmes P (1985) Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57: 65-73.
37. Braun A, Yesilaltay A, Acton S, Broschat K, Krul E, et al. (2008) Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice. Atherosclerosis 198: 77-84.
38. Karackattu S, Trigatti B, Krieger M (2006) Hepatic lipase deficiency delays atherosclerosis, myocardial infarction, and cardiac dysfunction and extends lifespan in SR-BI/Apolipoprotein E double knockout mice. Arterioscler Thromb Vasc Biol 2006: 548-554.
39. Karackattu S (2006) Genetic approaches to studying coronary heart disease in SR-BI/apoE double knockout mice. Karackattu, Sharon Liz Thesis (Ph D)- Massachusetts Institute of Technology, Dept of Biology, 2006.
40. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, et al. (1997) A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci U S A 94: 12610-12615.
41. Yesilaltay A, Morales M, Amigo L, Zanlungo S, Rigotti A, et al. (2006) Effects of hepatic expression of the high-density lipoprotein receptor SR-BI on lipoprotein metabolism and female infertility. Endocrinology 147: 1577-1588.
42. Zhang S, Picard M, Vasile E, Zhu Y, Raffai R, et al. (2005) Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient hypomorphic apolipoprotein ER61 mice. Circulation 111: 3457-3464.
43. Assanasen C, Mineo C, Seetharam D, Yuhanna IS, Marcel YL, et al. (2005) Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling. J Clin Invest 115: 969-977.
44. Webb NR, Connell PM, Graf GA, Smart EJ, De Villiers WJS, et al. (1998) SRBII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J Biol Chem 273: 15241-15248.
45. Braun A, Zhang S, Miettinen H, Ebrahim S, Holm T, et al. (2003) Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse. Proc Natl Acad Sci U S A 100: 7283-7288.
46. Herrera V, Makrides S, Xie H, Adari H, Krauss R, et al. (1999) Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein. Nat Med 5: 1383-1389.